[
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Safety Study on Turoctocog Alfa Pegol: Key Insights for Investors - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPUmxzR1czdDhzWWpFTFpvSG9RaXE4V19KdVVVSGR1cXJfRkJFaFlRY2RJcHV6ZE1xVDBRSnRfME5VX0x5MHRzNFAxQ3d6M3ItNk9FOElBVmt5WFh2Q1EwSUF3UVRIQVgtVXY0Q1JMSlRrTTNqZkVHUkZYamdsdV8zbkhRWmhXTk5BSWtINENGV3ByLWd1Z1JXa0N3Y2JZc1F4ck1JckhhUENWOGlNd1U4dm1ET2dXWm0xdGRqZ3FaLW5KWDZ2OHdkN0J3?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:14Z",
    "hash": "489ac8c257833607b3748c17829b3a6c240ca1ea53faea5bad6618f3d000b676",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Latest Diabetes Study: A Potential Game-Changer? - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNV2tvNFI2Ml9saUtyTVdBbHFXRTJHbkd2UF9QN3o3WlBVb2lYTDRhRG5Qek1uellidy1LaUJ6RjBiTDlGQWo1SG90U1VicGRfWlVoRWtNNkotWEl5TkswMHhMV1VPaWRRVXFxSXlWbTZFSTFseDBWaWFELWRHN2xmRnNTSFhRUXdaaHRyVFpPVTFHdTZDcFJIN3NZYUxBTU1QUXNlaFJTR1VMSFFtNl9ZMVdB?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:14Z",
    "hash": "507f35c7f4b3ab59afbeb6d7688524721ddda750b50c218053472d77a650f20c",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Real-World Study on Semaglutide: Implications for Obesity Management - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNSE5oZlRJemk2NmQ0dlptY2x6UlRNWGxxN0xBVW1RRDhna2w5RXVQNkRCREhOTXhqQlQ3X183eU5UZkR5S1hOV3VHWFhGeFdpVzMxcF9iYzE5WEU3M096dHRRcWN4bHpZUFdKMlRDSzZRTnhkTkZ3WURLVGNaSndreU5TeGxqTWt2LWFiY0JVMDIxdFhhbGFUek5jdmU0aGtXUHpvcFdfeWVHSUNjV3c1bDJnd2dRN3hsRDQ5WWg5MFd2YldVdXdnYTRmRFlVUQ?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:14Z",
    "hash": "0ece1576b190c1429baf1c336a8994394ddb1bc53dc4c13ef5bb866bdec0e13f",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Real-World Study on Wegovy: A Potential Game Changer in Obesity Management - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNVWFhV1NkYTcyeUlVQ3pZOWt4VlNLbFBtS3VHSmZjSWVmSms1NlRyRUZBdUFsdHBwU2d5R2Jfd3FzUloxXzc4cUtFenpfdnN3VVNBQXc3VnNVbXYyY3ZrdlhaNGJKbTFqX1BwM05WT2pVdDFSdk5aaVQyRzRLdS1TYlZvUDJsZzUzVkJOcWZWNlBoYzZBdkFvOGJ0N1RtZXc4dTBlTnZSOW5XSzlhNHVqUVNEbXdlc1JnMS1rOVVjQzN1V0wySkFlUkJndXNRTGR0al9VRTl3?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:14Z",
    "hash": "f1e516be3a220613e904e893668420ad909177694c9b829303b1edcc15fc9036",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Norditropin® Study: A Closer Look at Its Impact on Noonan Syndrome - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQU0Z4N1lzdW4zckFidndQZ3ExRTdZMTlSb2w2T3JYRF9yR0UyLUpDMXI1RkNkcDNtM1E3VGpuSHVvN014ME4xaE9Pem94QWh1Y3J1Rnc0Ym5tU2pSTDU2NjVUel9jOVI3NzdVSllydU5BTjM1RVpjUjd0WExqVEV2bDhDdlo0SWQ4Y043cjRublI0UFBXeUtueXhRdEY3elVva3laNmpsSk1TcUxhaTVlTnJXcm4wc1AtNnItOHRHMTNrNmN3eS0wcWhR?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:14Z",
    "hash": "581d7f626c8cedffbe5b140feeaaed9c14518eb02c8151a3a5f2ebf6a1fa0c86",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Study on Norditropin®: Impact on Growth Hormone Therapy Adherence - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxON1lib2M5Rl80MThVUFdtT01hR3FDeVRyZnhzX1VlUXhUanBUWWltOE9JOFZMS2VKRDY2QWMxcEhjbzY3YU5CZWNIb1BoYkJsMnpMVlFtNU03c1BpZjB2VXZ4Z2hCd2FyTGN1WVBFNDMySlZFMUp5cjRPNWNFOEJ3RGIzdVhFLVRQWElWb1laQkdmTzgzcnIwQ0RRd001M2RYSWp3NmZFMFZ2bW5ET0doVWZFN0dXdi1LczkwQUhBZFZ3RWNMRzFiYw?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:14Z",
    "hash": "a29f74468a2c47a323d04b315d5a6798868023aadc75579103243ac2dcb32246",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk’s Ongoing Observational Study on Parkinson’s Disease: Key Insights for Investors - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPZUFaMkVFYnhyZlc2R05zdEdzcE1lNDJVSkNkdEJUUEN0RGhLczlhQkdaUGI0Q0RrcXNjWnBOMW1XSGZxbHJMYi1UWGNORnBqaS0zQUpDMFUzOUZxWG9Ia0d0Q1JzOTJaWUlVTzhUT3RFVnVKZUZhWmNYQWlVY1psdjdFLXAzSXd6M0pPNjlDd1FuNDZnRXVha0RsVDRmS1JzWWVycGFSWlFJNzNZZDQtdDJ0d2pzQnFoZnlMNEo2WTJ6N2xpbnRyQ2NmNkdtSFdoWENJZ0lKX09oUQ?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:40:13Z",
    "hash": "7ed8cec7457faaeedf36fa7c1d343e34b4a044ef44e2d3ce2a8af8dff4afd756",
    "source": "gnews"
  },
  {
    "asset": "Bitcoin",
    "query": "BTC Bitcoin",
    "title": "American Bitcoin Reports 3,865 BTC in Reserves Following Latest Acquisition - Bitcoin.com News",
    "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPMFZTSVBLNEt1MUlBbGJwUzN1NHlvZ0ZVZEhtc2EzWnk0NEFaR2tlaHhsSHhYV21aNklyRTZZakpBN3NmZkw2aklDQlpwZF9RX3RxakVLNUJWQVRWVGRWaExGclVmWE5yRHNTNUZ5XzFqUVh6c0FuamJDWkN4cnA0ZEdVc1h4enZXNl9BNkVFc3g1QXBkRzFLVGVVR2FyOHduSGc?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:36:33Z",
    "hash": "fda9c6d19e28675610a741ec2a0b913590a318eaf1e32c13f31c705bcee70b8a",
    "source": "gnews"
  },
  {
    "asset": "Novo Nordisk",
    "query": "Novo Nordisk",
    "title": "Novo Nordisk Advances Sickle Cell Treatment with Etavopivat Study - TipRanks",
    "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOa2NjcVpVLXRnN3Njbkk0T1JmWVR6ZEdqX1V4Qmh4b1F3aldLSjd4d2g1QjB6dlVIMzN6clFjVWk5Q3Z3QzFtLWQ4VEhJcmlxdmtKX2R4bndwNTRDcGNaMWFRdTJVM2FoREJhaG5iZGFLbE4xZFFxSDdYblp5MC1JcnJTSDJ3RG9FSHpXcTRjNUU0ZlQya3NxdkZKLXFFVWJUMWJSdFh4bHJLZlJpNkZvYXpRUHI4MFVE?oc=5",
    "summary": "",
    "published_at_utc": "2025-10-27T21:29:51Z",
    "hash": "e32aa606fb7a3a161b8d407efbb8030fd33502f89cf417b20ff5c49bbb97e9a3",
    "source": "gnews"
  }
]